Pharma · Private company

Takeda

Track this companyFree. Adds Takeda to your Dealase workspace and tells you when its record changes.

Clinical trials2525 recruiting or active

Pipeline programs29From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline29

Active ComparatorPhase 3 · Psoriatic ArthritisClinicalTrials.gov · fetched Nov 12, 2026
Control ArmPhase 3 · IO Resistant Squamous and Nonsquamous NSCLCClinicalTrials.gov · fetched Nov 12, 2026
ElriterceptPhase 3 · MyelofibrosisClinicalTrials.gov · fetched Nov 12, 2026
ElriterceptPhase 3 · Myelodysplastic SyndromeClinicalTrials.gov · fetched Nov 12, 2026
ElriterceptPhase 3 · Myelodysplastic SyndromesClinicalTrials.gov · fetched Nov 12, 2026
Epoetin AlfaPhase 3 · Myelodysplastic SyndromeClinicalTrials.gov · fetched Nov 12, 2026
MezagitamabPhase 3 · Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
MezagitamabPhase 3 · Immune Thrombocytopenic Purpura (ITP)ClinicalTrials.gov · fetched Nov 12, 2026
TAK-360Phase 3 · Idiopathic HypersomniaClinicalTrials.gov · fetched Nov 12, 2026
TAK-861Phase 3 · Narcolepsy Type 1 (NT1)ClinicalTrials.gov · fetched Nov 12, 2026
TAK-928Phase 3 · IO Resistant Squamous and Nonsquamous NSCLCClinicalTrials.gov · fetched Nov 12, 2026
ZasocitinibPhase 3 · Psoriatic ArthritisClinicalTrials.gov · fetched Nov 12, 2026
Brentuximab vedotinPhase 2 · Hodgkin DiseaseClinicalTrials.gov · fetched Nov 12, 2026
DacarbazinePhase 2 · Hodgkin DiseaseClinicalTrials.gov · fetched Nov 12, 2026
DoxorubicinPhase 2 · Hodgkin DiseaseClinicalTrials.gov · fetched Nov 12, 2026
MezagitamabPhase 2 · Antibody-Mediated Rejection (AMR)ClinicalTrials.gov · fetched Nov 12, 2026
TAK-279Phase 2 · Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
TAK-411Phase 2 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)ClinicalTrials.gov · fetched Nov 12, 2026
TAK-505Phase 2 · Malignant Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
VinblastinePhase 2 · Hodgkin DiseaseClinicalTrials.gov · fetched Nov 12, 2026
ZasocitinibPhase 2 · Nonsegmental VitiligoClinicalTrials.gov · fetched Nov 12, 2026
Zasocitinib (Dose A)Phase 2 · Hidradenitis SuppurativaClinicalTrials.gov · fetched Nov 12, 2026
AdalimumabCrohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
TofacitinibUlcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
UstekinumabCrohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
VedolizumabCrohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
VedolizumabUlcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
Vedolizumab IVUlcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
Vedolizumab SCUlcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney TransplantPHASE2 · RECRUITING · started Oct 27, 2026ClinicalTrials.gov NCT07613359 · fetched Nov 12, 2026
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking RuxolitinibPHASE3 · RECRUITING · started Sep 10, 2026ClinicalTrials.gov NCT07623161 · fetched Nov 12, 2026
A Study of TAK-360 in People With Narcolepsy or Idiopathic HypersomniaPHASE2_PHASE3 · RECRUITING · started Jun 11, 2026ClinicalTrials.gov NCT07646678 · fetched Nov 12, 2026
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood TransfusionsPHASE3 · RECRUITING · started May 21, 2026ClinicalTrials.gov NCT07422480 · fetched Nov 12, 2026
A Study of TAK-505 in Adults With Solid TumorsPHASE1_PHASE2 · RECRUITING · started May 11, 2026ClinicalTrials.gov NCT07436728 · fetched Nov 12, 2026
A Trial of TAK-861 for the Treatment of Narcolepsy With CataplexyPHASE3 · ACTIVE_NOT_RECRUITING · started Jan 29, 2026ClinicalTrials.gov NCT07363720 · fetched Nov 12, 2026
A Study of Zasocitinib in Adults With Hidradenitis SuppurativaPHASE2 · ACTIVE_NOT_RECRUITING · started Jan 26, 2026ClinicalTrials.gov NCT07244263 · fetched Nov 12, 2026
A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung CancerPHASE3 · RECRUITING · started Nov 26, 2025ClinicalTrials.gov NCT07217301 · fetched Nov 12, 2026
A Study of Zasocitinib in Adults With Nonsegmental VitiligoPHASE2 · ACTIVE_NOT_RECRUITING · started Nov 3, 2025ClinicalTrials.gov NCT07108283 · fetched Nov 12, 2026
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaPHASE3 · RECRUITING · started Aug 14, 2025ClinicalTrials.gov NCT06948318 · fetched Nov 12, 2026
A Study of Mezagitamab in Adults With Kidney Condition Called IgA NephropathyPHASE3 · RECRUITING · started Jul 15, 2025ClinicalTrials.gov NCT06963827 · fetched Nov 12, 2026
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)PHASE2 · RECRUITING · started May 14, 2025ClinicalTrials.gov NCT06798012 · fetched Nov 12, 2026
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsPHASE3 · RECRUITING · started May 6, 2025ClinicalTrials.gov NCT06499285 · fetched Nov 12, 2026
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community SettingPHASE4 · RECRUITING · started Mar 27, 2025ClinicalTrials.gov NCT06581328 · fetched Nov 12, 2026
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesPHASE3 · RECRUITING · started Mar 3, 2025ClinicalTrials.gov NCT06671483 · fetched Nov 12, 2026
A Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaPHASE3 · RECRUITING · started Feb 27, 2025ClinicalTrials.gov NCT06722235 · fetched Nov 12, 2026
Vedolizumab for the Treatment of Collagenous GastritisPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 3, 2024ClinicalTrials.gov NCT06317220 · fetched Nov 12, 2026
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)PHASE4 · ACTIVE_NOT_RECRUITING · started Jun 12, 2024ClinicalTrials.gov NCT06095128 · fetched Nov 12, 2026
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's DiseasePHASE4 · ACTIVE_NOT_RECRUITING · started Apr 18, 2024ClinicalTrials.gov NCT06045754 · fetched Nov 12, 2026
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational StudyACTIVE_NOT_RECRUITING · started Mar 20, 2024ClinicalTrials.gov NCT06249555 · fetched Nov 12, 2026
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's DiseasePHASE2 · RECRUITING · started Mar 5, 2024ClinicalTrials.gov NCT06233461 · fetched Nov 12, 2026
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)PHASE2 · RECRUITING · started Aug 19, 2020ClinicalTrials.gov NCT04419649 · fetched Nov 12, 2026
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)PHASE2 · RECRUITING · started Jun 20, 2020ClinicalTrials.gov NCT04374305 · fetched Nov 12, 2026
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic LeukemiaPHASE2 · RECRUITING · started Nov 29, 2017ClinicalTrials.gov NCT03263572 · fetched Nov 12, 2026
A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin LymphomaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 6, 2017ClinicalTrials.gov NCT02979522 · fetched Nov 12, 2026